In addition to new bone substitutes that extend the comprehensive creos regenerative assortment, a wide range of other innovative products were unveiled at the Nobel Biocare Global Symposium 2016 in New York. Here is a glimpse of a few of them.

The primary research focus in implant dentistry has shifted since Professor Brånemark’s early days. Now that the average implant survival rates have successfully exceeded 97%, research focuses on reducing treatment time, enhancing comfort and improving esthetics.